PPIDT00056
Drug Information
| Name | Follitropin |
|---|---|
| Sequence | APDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRAYPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS |
| DrugBank_ID | DB00066 |
| Type | biotech |
| Indication | In women having been diagnosed with primary ovarian failure, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. In men with hypogonadotrophic hypogonadism, it is used to induce spermatogenesis. Follitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use in gamete intrafallopian transfer (GIFT) or in vitro fertilization (IVF). |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, solution | Subcutaneous |
150 IU/0.25ML
|
| Injection, solution | Subcutaneous |
225 IU/0.375ML
|
| Injection, solution | Subcutaneous |
225 IU/3.75ML
|
| Injection, solution | Subcutaneous |
300 IU/0.50ML
|
| Injection, solution | Subcutaneous |
75 IU/0.125ML
|
| Solution | Subcutaneous |
75 UI
|
| Solution | Subcutaneous |
150 IU
|
| Solution | Subcutaneous |
15000000 IU
|
| Solution | Subcutaneous |
300 IU
|
| Solution | Subcutaneous |
75 IU
|
| Solution | Subcutaneous |
7500000 IU
|
| Kit | Intramuscular; Subcutaneous |
|
| Injection, solution | Intramuscular; Subcutaneous |
150 [iU]/0.5mL
|
| Injection, solution | Intramuscular; Subcutaneous |
75 [iU]/0.5mL
|
| Injection, solution | Subcutaneous |
175 [iU]/0.210mL
|
| Injection, solution | Subcutaneous |
300 [iU]/0.36mL
|
| Injection, solution | Subcutaneous |
350 [iU]/0.42mL
|
| Injection, solution | Subcutaneous |
600 [iU]/0.72mL
|
| Injection, solution | Subcutaneous |
650 [iU]/0.78mL
|
| Injection, solution | Subcutaneous |
900 [iU]/1.08mL
|
| Injection, solution | Subcutaneous |
975 [iU]/1.17mL
|
| Solution | — |
150 iu/1vial
|
| Injection, powder, for solution | — |
1050 IU/1.75ml
|
| Injection, powder, for solution | — |
75 IU
|
| Powder | — |
75 iu/1vial
|
| Solution | Subcutaneous |
75 UI
|
| Injection, powder, lyophilized, for solution | Subcutaneous |
3750000 IU
|
| Injection, powder, for solution | Parenteral; Subcutaneous |
1050 IU/1.75ML
|
| Injection, powder, for solution | Parenteral; Subcutaneous |
150 IU
|
| Injection, powder, for solution | Parenteral; Subcutaneous |
300 IU/0.5ML
|
| Injection, powder, for solution | Parenteral; Subcutaneous |
37.5 IU
|
| Injection, powder, for solution | Parenteral; Subcutaneous |
450 IU/0.75ML
|
| Injection, powder, for solution | Parenteral; Subcutaneous |
75 IU
|
| Injection, powder, for solution | Subcutaneous |
1050 IU/1.75ml
|
| Injection, powder, for solution | Subcutaneous |
150 IU
|
| Injection, powder, for solution | Subcutaneous |
300 IU/0.5ml
|
| Injection, powder, for solution | Subcutaneous |
75 IU/ML
|
| Injection; injection, solution | Subcutaneous |
300 IU/0.5ml
|
| Kit | Subcutaneous |
1050 [iU]/2mL
|
| Kit | Subcutaneous |
450 [iU]/1mL
|
| Powder, for solution | Intramuscular; Subcutaneous |
1200 unit / vial
|
| Powder, for solution | Intramuscular; Subcutaneous |
150 unit / vial
|
| Powder, for solution | Intramuscular; Subcutaneous |
33 mcg / vial
|
| Powder, for solution | Intramuscular; Subcutaneous |
37.5 unit / vial
|
| Powder, for solution | Intramuscular; Subcutaneous |
5.5 mcg / vial
|
| Powder, for solution | Intramuscular; Subcutaneous |
75 unit / vial
|
| Powder, for solution | Intramuscular; Subcutaneous |
77 mcg / vial
|
| Injection, powder, lyophilized, for solution | Subcutaneous |
1050 iu/1.75ml
|
| Injection | Subcutaneous |
150 iu
|
| Injection, solution | Subcutaneous |
300 iu/0.5ml
|
| Injection, solution | Subcutaneous |
22.23 mcg
|
| Solution | — |
300 iu/0.5ml
|
| Injection | Subcutaneous |
37.5 iu
|
| Injection, solution | Subcutaneous |
450 iu/0.75ml
|
| Injection, powder, lyophilized, for solution | Subcutaneous |
450 iu/0.75ml
|
| Injection, solution | Subcutaneous |
33.34 mcg
|
| Solution | — |
450 iu/0.75ml
|
| Injection, powder, lyophilized, for solution | Subcutaneous |
75 iu
|
| Injection, solution | Subcutaneous |
66.69 mcg
|
| Injection, solution | Subcutaneous |
900 iu/1.5ml
|
| Solution | — |
900 iu/1.5ml
|
| Injection, powder, for solution | Subcutaneous |
75 IU
|
| Injection, powder, for solution | Subcutaneous |
600 iu/ml
|
| Solution | Subcutaneous |
300 unit / 0.5 mL
|
| Solution | Subcutaneous |
450 unit / 0.75 mL
|
| Solution | Subcutaneous |
900 unit / 1.5 mL
|
| Kit | Subcutaneous |
75 [iU]/1mL
|
| Injection, solution | Subcutaneous |
300 [iU]/0.5mL
|
| Injection, solution | Subcutaneous |
450 [iU]/0.75mL
|
| Injection, solution | Subcutaneous |
900 [iU]/1.5mL
|
| Injection, solution | Subcutaneous |
150 [iU]/0.25mL
|
| Injection, powder, for solution | Subcutaneous |
450 IU/0.75ml
|
| Injection, solution | Subcutaneous |
22 mcg/0.5ml
|
| Liquid; powder, for solution | Intramuscular |
|
| Injection; injection, powder, lyophilized, for solution; kit | Subcutaneous |
|
| Injection, powder, lyophilized, for solution | Subcutaneous |
|
| Injection, powder, lyophilized, for solution | Intramuscular; Subcutaneous |
|
| Injection, powder, for solution | Intramuscular; Subcutaneous |
|
| Powder, for solution | Intramuscular |
|
| Injection, powder, for solution; injection, solution | Subcutaneous |
|
| Kit; powder, for solution | Subcutaneous |
|
| Powder | Parenteral; Subcutaneous |
|
| Solution | Subcutaneous |
|
| Injection | Subcutaneous |
|
| Injection, powder, for solution | Subcutaneous |
|
| Injection, powder, for solution | Subcutaneous |
150 IU
|
| Injection, solution | Subcutaneous |
300 IU/0.48ml
|
| Injection, solution | Subcutaneous |
450 IU/0.72ml
|
| Injection, solution | Subcutaneous |
900 IU/1.44ml
|
| Injection, solution | Intramuscular; Subcutaneous |
100 IU/0.5ML
|
| Injection, solution | Intramuscular; Subcutaneous |
150 IU/0.5ML
|
| Injection, solution | Intramuscular; Subcutaneous |
200 IU/0.5ML
|
| Injection, solution | Intramuscular; Subcutaneous |
225 IU/0.5ML
|
| Injection, solution | Intramuscular; Subcutaneous |
250 IU/0.5ML
|
| Injection, solution | Intramuscular; Subcutaneous |
300 IU/0.36ML
|
| Injection, solution | Intramuscular; Subcutaneous |
50 IU/0.5ML
|
| Injection, solution | Intramuscular; Subcutaneous |
600 IU/0.72ML
|
| Injection, solution | Intramuscular; Subcutaneous |
75 IU/0.5ML
|
| Injection, solution | Subcutaneous |
150 IU/0.18mL
|
| Injection, solution | Subcutaneous |
300 IU/0.36mL
|
| Injection, solution | Subcutaneous |
900 IU/1.08ml
|
| Solution | — |
833 iu/1ml
|
| Solution | Intramuscular; Subcutaneous |
100 unit / 0.5 mL
|
| Solution | Intramuscular; Subcutaneous |
100 IU/0.5ml
|
| Solution | Intramuscular; Subcutaneous |
150 IU/0.5ml
|
| Solution | Intramuscular; Subcutaneous |
50 IU/0.5ml
|
| Solution | Intramuscular; Subcutaneous |
50 unit / 0.5 mL
|
| Solution | Intramuscular; Subcutaneous |
75 IU/0.5ml
|
| Solution | Parenteral |
150.000 UI
|
| Solution | Subcutaneous |
833 unit / mL
|
| Powder, for solution; solution | Intramuscular; Subcutaneous |
737 unit / cartridge
|
| Injection, powder, lyophilized, for solution | Parenteral |
10000000 IU
|
| Injection, powder, lyophilized, for solution | Parenteral |
15000000 IU
|
| Solution | Parenteral |
40000000 IU
|
| Solution | Intramuscular; Subcutaneous |
300 IU/0.36ml
|
| Injection, solution | — |
300 iu/0.36ml
|
| Liquid; powder, for solution | Intramuscular; Subcutaneous |
|
| Injection, powder, for suspension | Parenteral |
5000000 IU
|
| Solution | Intramuscular; Subcutaneous |
600 IU/0.72ml
|
| Injection, solution | — |
600 iu/0.72ml
|
| Injection, powder, lyophilized, for solution | Parenteral |
7500000 IU
|
| Solution | Parenteral |
7500000 IU
|
| Injection, solution | — |
900 iu/1.08ml
|
| Solution | Intramuscular; Subcutaneous |
900 IU/1.08ml
|
| Injection | Intramuscular; Subcutaneous |
100 iu/0.5ml
|
| Injection | Subcutaneous |
833 IU/ml
|
| Injection | Intramuscular; Subcutaneous |
50 iu/0.5ml
|
| Injection, solution | Subcutaneous |
600 IU/0.72ml
|
| Injection, solution | Subcutaneous |
833 IU/ml
|
| Solution | Intramuscular; Subcutaneous |
10000000 IU
|
| Solution | Intramuscular; Subcutaneous |
5000000 IU
|
| Injection, solution | — |
72 mcg/2.16ml
|
| Injection, solution | Cutaneous; Parenteral |
36 MCG/1.08ML
|
| Injection, solution | Cutaneous; Parenteral |
72 MCG/2.16ML
|
| Injection, solution | Intramuscular; Subcutaneous |
12 MCG/0.36ML
|
| Injection, solution | Intramuscular; Subcutaneous |
36 MCG/1.08ML
|
| Injection, solution | Subcutaneous |
12 ?g/0.36ml
|
| Injection, solution | Subcutaneous |
36 ?g/1.08ml
|
| Injection, solution | Subcutaneous |
72 ?g/2.16ml
|
| Solution | Subcutaneous |
12 mcg / 0.36 mL
|
| Solution | Subcutaneous |
12.000 mcg
|
| Solution | Subcutaneous |
36 mcg / 1.08 mL
|
| Solution | Subcutaneous |
72 mcg / 2.16 mL
|
| Injection, solution | Subcutaneous |
|
| Injection, solution | Subcutaneous |
12.0 mcg
|
| Injection, solution | Subcutaneous |
36.0 mcg
|
| Injection, solution | Subcutaneous |
72.0 mcg
|
| Solution | Subcutaneous |
3330000 mcg
|
| Solution | Subcutaneous |
225 UI
|
| Solution | — |
75 IU/0.15ml
|
| Injection, solution | — |
150 iu/1ml
|
| Injection, solution | — |
75 iu/1ml
|
| Injection, solution | Subcutaneous |
|
| Solution | — |
100 iu/0.5ml
|